Core Viewpoint - Fujian Huaxing Venture Capital Co., Ltd. plans to reduce its holdings in Tengjing Technology Co., Ltd. by up to 2,540,349 shares, representing approximately 1.9639% of the total share capital, primarily to meet its own funding needs and fulfill commitments made during the initial public offering [2][3][9] Shareholder Holding Situation - As of the announcement date, Fujian Huaxing Venture Capital Co., Ltd. holds 2,540,349 shares of Tengjing Technology, accounting for 1.9639% of the total share capital, with these shares originating from holdings prior to the company's initial public offering [2][3] Reduction Plan Details - The reduction will be executed through block trading, with a maximum of 2,540,349 shares to be sold within three months starting from three trading days after the announcement [3][4] - Any corporate actions such as stock dividends or capital increases during the reduction period will lead to adjustments in the number of shares to be reduced [3] Shareholder Commitment - Fujian Huaxing Venture Capital Co., Ltd. had previously committed to a lock-up period of 12 months post-IPO, during which it would not transfer or manage its shares [6][7] - The shareholder has confirmed that the planned reduction aligns with prior commitments and does not involve any controlling shareholder or actual controller reducing pre-IPO shares [5][9] Compliance with Regulations - The reduction plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China, and will be conducted in accordance with the rules of the Shanghai Stock Exchange [9]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，12月2日，盘后志邦家居披露增持情况。包括腾景科技、东方电气、佰维存储、山西汾酒、唯 赛勃、银邦股份、安孚科技、国博电子、坚朗五金、腾达科技、天山铝业、棒杰股份、熊猫乳品、德尔 股份、华凯易佰在内的15家A股上市公司披露减持情况。 | | | 12.3上市公司盘后增持情况 | | --- | --- | --- | | 1 | 志邦家居 | 拟以8000万元至1.1亿元回购公司股份 | | | | 12.3上市公司盘后减持情况 | | 1 | 腾景科技 | 股东拟减持不超1.96%公司股份 | | 2 | 东方电气 | 股东合计拟减持不超3万股公司股份 | | 3 | 山西汾酒 | 第二大股东华创鑫睿已减持1.33%公司股份 | | র্ব | 唯惠勃 | 控股股东拟减持不超2.99%股份 | | 5 | 佰维存储 | 第二大股东国家大基金二期近期减持464.6万股 | | 6 | 安孚科技 | 股东秦大乾拟减持不超1.00%股份 | | 7 | 银邦股份 | 股东无锡新邦科技减持3%股份 | | 8 | 国博电子 | 股东中电 ...

①濮阳开州投资集团拟发行8亿元公司债，获上交所通过； ②因涉嫌内幕交易等，贵州百灵实控人姜伟被证监会立案； 实习编辑:金怡杉 | 审核:李震 | 监审:古筝 ③星宇股份筹划发行H股股票并在港交所上市； ④德固特终止筹划重大资产重组事项； ⑤国发股份董事长姜烨因个人原因辞任，辞任后不再担任该公司及控股子公司任何职务； ⑥山西汾酒股东华创鑫睿减持计划实施完毕，共减持1620万股该公司股份，占该公司总股本的1.33%； ⑦唯赛勃控股股东香港唯赛勃拟减持不超过520万股该公司股份，即不超过该公司总股本的2.99%； ⑧腾景科技股东福建华兴拟减持不超过254.03万股该公司股份，即不超过该公司总股本的1.96%； ⑨长盈通董事柳祎因个人原因辞职，辞职后不再担任该公司任何职务； ⑩因近期市场波动较大，开滦集团决定取消发行"25开滦MTN006"。 #成为立方风控鸟会员，尊享直播版风控服务# ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

腾景科技(688195.SH)发布公告，国有资本投资项目到期及自身资金需求，福建华兴创业投资有限公司 计划以大宗交易的方式减持其持有的公司股份，合计减持数量不超过254.03万股(占公司总股本的比例 不超过1.9639%)，减持期间为自公告披露之日起三个交易日后的三个月内。 ...

格隆汇12月3日丨腾景科技(688195.SH)公布，公司于近日收到福建华兴创业投资有限公司出具的《关于 股份减持计划的告知函》，国有资本投资项目到期及自身资金需求，福建华兴创业投资有限公司计划以 大宗交易的方式减持其持有的公司股份，合计减持数量不超过254.03万股（占公司总股本的比例不超过 1.96%），减持期间为自本公告披露之日起三个交易日后的三个月内。 ...

腾景科技公告，股东福建华兴创业投资有限公司计划以大宗交易方式减持其持有的公司股份，合计不超 过254.03万股，占总股本比例不超过1.9639%。减持原因为国有资本投资项目到期及自身资金需求，减 持期间为自公告披露之日起三个交易日后的三个月内。 (本文来自第一财经) ...

证券代码：688195 证券简称：腾景科技 公告编号：2025-060 腾景科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，股东福建华兴创业投资有限公司直接持有腾景科技股份 有限公司（以下简称"公司"、"腾景科技"）股份 2,540,349 股，占公司总股本 比例为 1.9639%。上述股份来源于公司首次公开发行前持有的股份。 该股东目前持股比例 5%以下，本次披露减持公告主要是履行其在首次公开 发行股票招股说明书中所作出的关于股份减持的信息披露承诺。 减持计划的主要内容 国有资本投资项目到期及自身资金需求，福建华兴创业投资有限公司计划以 大宗交易的方式减持其持有的公司股份，合计减持数量不超过 2,540,349 股（占 公司总股本的比例不超过 1.9639%），减持期间为自本公告披露之日起三个交易 日后的三个月内。 若公司在减持计划实施期间发生送红股、转增股本、增发新股或配股等股本 除权、除息事项的，则减持股份数量将 ...

格隆汇12月3日丨腾景科技(688195.SH)公布，公司于近日收到福建华兴创业投资有限公司出具的《关于 股份减持计划的告知函》，国有资本投资项目到期及自身资金需求，福建华兴创业投资有限公司计划以 大宗交易的方式减持其持有的公司股份，合计减持数量不超过254.03万股（占公司总股本的比例不超过 1.96%），减持期间为自本公告披露之日起三个交易日后的三个月内。 ...

人民财讯12月3日电，腾景科技(688195)12月3日公告，持股1.96%的股东福建华兴创业投资有限公司计 划3个交易日后的3个月内，以大宗交易的方式，减持公司股份不超过254.03万股(占公司总股本的 1.96%)。 ...